266 related articles for article (PubMed ID: 32576056)
21. Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
Schroeder JW; Napoli C; Caputo V; Bonoldi E; Rongioletti F
Clin Dermatol; 2023; 41(6):721-728. PubMed ID: 37730074
[TBL] [Abstract][Full Text] [Related]
22. Trimethoprim-Sulfamethoxazole-Induced Drug Eruption With Eosinophilia and Systemic Symptoms (DRESS).
Antia C; Persad L; Alikhan A
J Drugs Dermatol; 2017 Oct; 16(10):1043-1046. PubMed ID: 29036260
[TBL] [Abstract][Full Text] [Related]
23. Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Sharpe A; Mourad BM; Hardwick CJ; Reilly T; Dweck E; Bondarsky E
Am J Case Rep; 2019 Mar; 20():345-348. PubMed ID: 30877266
[TBL] [Abstract][Full Text] [Related]
24. DRESS syndrome: Addressing the drug hypersensitivity syndrome on combination of Sodium Valproate and Olanzapine.
Penchilaiya V; Kuppili PP; Preeti K; Bharadwaj B
Asian J Psychiatr; 2017 Aug; 28():175-176. PubMed ID: 28784381
[TBL] [Abstract][Full Text] [Related]
25. An Uncommon Presentation of DRESS Syndrome Secondary to Leflunomide Use: A Case Report.
Rao S; Sunkara A; Srivastava N; Sampat P; Ramos C; Albert E
J Investig Med High Impact Case Rep; 2021; 9():2324709621997282. PubMed ID: 33629602
[TBL] [Abstract][Full Text] [Related]
26. Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Fong CY; Hashim N; Gan CS; Chow TK; Tay CG
Eur J Paediatr Neurol; 2016 Nov; 20(6):957-961. PubMed ID: 27524391
[TBL] [Abstract][Full Text] [Related]
27. A Rare Presentation of Clozapine-Induced DRESS Syndrome.
Moazez C; Rudha Y; Narang N; Younger T
Case Rep Med; 2018; 2018():1346351. PubMed ID: 29991947
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.
Mehrholz D; Urban AE; Herstowska M; Nowicki R; Cubała W; Barańska-Rybak W
Psychiatr Pol; 2017 Dec; 51(6):1079-1093. PubMed ID: 29432504
[TBL] [Abstract][Full Text] [Related]
29. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
30. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.
Cho YT; Yang CW; Chu CY
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598363
[TBL] [Abstract][Full Text] [Related]
31. Skin reaction with Eosinophilia and Systemic Symptoms after lenalidomide in peritoneal Dialysis.
Cazzato S; Fontana F; Maccaferri M; Leonelli M; Ascione E; Magistroni R; Alfano G
G Ital Nefrol; 2022 Oct; 39(5):. PubMed ID: 36563074
[TBL] [Abstract][Full Text] [Related]
32. Drug reaction with eosinophilia and systemic symptoms syndrome.
Spriet S; Banks TA
Allergy Asthma Proc; 2015; 36(6):501-5. PubMed ID: 26534757
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
34. Myocarditis Associated with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Literature.
Morikawa D; Hiraoka E; Obunai K; Norisue Y
Am J Case Rep; 2018 Aug; 19():978-984. PubMed ID: 30122752
[TBL] [Abstract][Full Text] [Related]
35. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome.
de Filippis R; De Fazio P; Kane JM; Schoretsanitis G
Expert Opin Drug Saf; 2022 May; 21(5):585-587. PubMed ID: 35417282
[No Abstract] [Full Text] [Related]
36. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationale.
Azorin JM; Simon N
Expert Opin Drug Metab Toxicol; 2020 Dec; 16(12):1175-1186. PubMed ID: 32930009
[TBL] [Abstract][Full Text] [Related]
39. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
Gottlieb M; Figlewicz MR; Rabah W; Buddan D; Long B
Am J Emerg Med; 2022 Jun; 56():1-6. PubMed ID: 35338896
[TBL] [Abstract][Full Text] [Related]
40. A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.
Zhang Y; Wang X; Cheng Y; Wang X; Zhang Y
BMC Pulm Med; 2022 Jul; 22(1):279. PubMed ID: 35854287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
